Open-Label Extension Trial to Characterize the Long-term Safety and Tolerability of Elamipretide in Subjects With Genetically Confirmed Primary Mitochondrial Myopathy (PMM)

Name: Open-Label Extension Trial to Characterize the Long-term Safety and Tolerability of Elamipretide in Subjects With Genetically Confirmed Primary Mitochondrial Myopathy (PMM)
Published: 2016
License: Public Domain

Stealth BioTherapeutics Inc. · 2016

ClinicalTrials.gov · Datasets · License: Public Domain · 2016

Open Source ↗

primary mitochondrial disease, stealth, elamipretide, interventional, phase2

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Open-Label Extension Trial to Characterize the Long-term Safety and Tolerability of Elamipretide in Subjects With Genetically Confirmed Primary Mitochondrial Myopathy (PMM)

Related documents